What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.

Saved in:
Bibliographic Details
Title: What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.
Authors: Varma A; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Bolotin S; Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., De Serres G; Faculty of Medicine, Laval University, Quebec, Canada., Didierlaurent AM; Center of vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Earle K; Vaccine Development, Bill & Melinda Gates Foundation, Washington, United States., Frey K; Institute for Disease Modelling, Bill & Melinda Gates Foundation, Washington, United States., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Kapelus D; Wits Vaccines and Infectious Diseases Analytics Research Unit, University of Witwatersrand, Johannesburg, South Africa., Krause LK; Immunization, Bill & Melinda Gates Foundation, Washington, United States., McCarthy K; Institute for Disease Modelling, Bill & Melinda Gates Foundation, Washington, United States., Moss WJ; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Orenstein WA; Emory Vaccine Center, Emory University, Atlanta, United States., van Binnendijk R; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Vittrup DM; Child and adolescent Department, Rigshospitalet, Copenhagen, Denmark., Voysey M; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom., Woudenberg T; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Bar-Zeev N; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Bose AS; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Hombach J; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Mulders MN; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Lochlainn LN; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Suwintono K; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Feikin DR; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland., Crowcroft NS; Department of Immunization, Vaccines, and Biologicals World Health Organization, Geneva, Switzerland. Electronic address: natasha.crowcroft@utoronto.ca.
Source: Vaccine [Vaccine] 2025 May 31; Vol. 57, pp. 127187. Date of Electronic Publication: 2025 May 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2025.127187